USPTO serial 79406501
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kevan L. Morgan
Kevan L. Morgan Seed IP Law Group LLP701 Fifth AvenueSuite 5400Seattle, WA 98104| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations and diagnostic agents for scientific purposes and research use; diagnostic agents for scientific purposes and research use, in particular immobilized cells or viruses or components thereof, immobilized cell or tissue extracts or lysates, immobilized nucleic acids, immobilized proteins, immobilized polypeptides, immobilized peptides, immobilized antigens, immobilized allergens or immobilized antibodies on a carrier or a carrier material, in particular a microbead, nanobead, microsphere, magnetic particle, plastic or glass support; diagnostic test kits for scientific purposes and research use, whereby the aforementioned goods comprise monoclonal or polyclonal antibodies, antigens, allergens, proteins, polypeptides, peptides, nucleic acids, cells or viruses or components thereof, or cell or tissue extracts or lysates; diagnostic or research tests and test kits for scientific purposes and research use, whereby the aforementioned goods comprise diagnostic agents for the determination of the presence of a cell or virus or component thereof, nucleic acid, protein, polypeptide, peptide, antigen, allergen, hormone, steroid hormone, vitamin or antibody, in particular in a sample of biological origin, in particular blood, serum, plasma, cerebrospinal fluid, saliva, nasal swab, throat swab, faeces or urine. | ACTIVE | — |
| 005 | Diagnostic preparations for medical and pharmaceutical purposes, in particular test kits comprising immunoassay cartridges, magnetic particles, microbeads, nanobeads and microspheres; diagnostic preparations for medical and veterinary purposes; diagnostic preparations, in particular diagnostic preparations for medical and veterinary purposes for the detection of allergies, neurological diseases, food intolerances, metabolic diseases, endocrine disorders, inflammation, infectious diseases, autoimmune diseases or cancers; diagnostic preparations, in particular diagnostic preparations for medical and veterinary purposes for the detection and measurement of drug and anti-drug antibodies, treatment and therapy efficiency monitoring, or monitoring or diagnosis or prognosis or prevention of diseases; diagnostic preparations, in particular diagnostic preparations for medical and veterinary purposes for use as companion diagnostics; companion diagnostic agents for medical use; diagnostic agents for medical and veterinary purposes, in particular immobilized cells or viruses or components thereof, immobilized cell or tissue extracts or lysates, immobilized nucleic acids, immobilized proteins, immobilized polypeptides, immobilized peptides, immobilized antigens, immobilized allergens or immobilized antibodies on a carrier or a carrier material, in particular a microbead, nanobead, microsphere, magnetic particle, plastic or glass support; reagents for medical and veterinary diagnostic purposes; kits for in vitro diagnostic testing comprising immunoassay cartridges, magnetic particles, microbeads, nanobeads and microspheres for the detection of allergies, neurological diseases, food intolerances, metabolic diseases, endocrine disorders, inflammation, infectious diseases, autoimmune diseases or cancers; diagnostic test kits for medical and veterinary purposes, whereby the aforesaid goods comprise diagnostic agents for conducting tests on samples of biological origin, in particular blood, serum, plasma, cerebrospinal fluid, saliva, nasal swab, throat swab, faeces and urine; immunoserological test kits, comprising diagnostic agents for conducting immunoserological tests for medical purposes; quantitative immunoglobulin test kits comprising capture and detection agents, calibrator reagents and controls for detecting the presence of immunoglobulin A (IgA), IgG, IgM or IgE antibodies for medical purposes; diagnostic test kits for medical and veterinary purposes, whereby the aforesaid goods comprise surface modified or surface activated microbeads, nanobeads or magnetic particles enabling the coupling of cells or viruses or components thereof, nucleic acids, proteins, polypeptides, peptides, antigens, allergens or antibodies. | ACTIVE | — |
| 009 | Scientific instruments for diagnosis, namely, chemiluminescence diagnostic apparatus for detecting the presence of immunoglobulin A (IgA), IgG, IgM or IgE antibodies, proteins, and antigens; diagnostic apparatus not for medical purposes, namely, chemiluminescence diagnostic apparatus for detecting the presence of immunoglobulin A (IgA), IgG, IgM or IgE antibodies, proteins, and antigens, not for medical purposes; diagnostic apparatus for research laboratory use, namely, chemiluminescence apparatus for detecting the presence of immunoglobulin A (IgA), IgG, IgM or IgE antibodies, proteins, and antigens, for research laboratory use; testing apparatus for diagnostic purposes, namely, chemiluminescence testing apparatus for detecting the presence of immunoglobulin A (IgA), IgG, IgM or IgE antibodies, proteins, and antigens, for diagnostic purposes; measuring apparatus not for medical purposes, namely, chemiluminscence measuring apparatus for detecting the presence of immunoglobulin A (IgA), IgG, IgM or IgE antibodies, proteins, and antigens, not for medical purposes; laboratory instruments, in particular chemiluminscence measurement laboratory instruments; downloadable software, in particular laboratory software for detecting the presence of immunoglobulin A (IgA), IgG, IgM or IgE antibodies, proteins, and antigens | ACTIVE | — |
| 010 | Diagnostic instruments for medical use, namely, chemiluminescence instruments for detecting the presence of immunoglobulin A (IgA), IgG, IgM or IgE antibodies, proteins, and antigens; diagnostic, examination, and monitoring equipment, namely, chemiluminescence equipment for detecting the presence of immunoglobulin A (IgA), IgG, IgM or IgE antibodies, proteins, and antigens; diagnostic measuring apparatus for medical use, in particular namely, diagnostic chemiluminescence measuring apparatus for measuring levels of immunoglobulin A (IgA), IgG, IgM or IgE antibodies, proteins, and antigens; medical diagnostic apparatus for medical purposes, namely, chemiluminescence apparatus for detecting the presence of immunoglobulin A (IgA), IgG, IgM or IgE antibodies, proteins, and antigens; medical diagnostic testing instruments for use in immunoassay procedure, namely, chemiluminescence testing instruments for detecting the presence of immunoglobulin A (IgA), IgG, IgM or IgE antibodies, proteins, and antigens; diagnostic apparatus for medical purposes used in medical laboratories, namely, diagnostic chemiluminescence apparatus for detecting the presence of immunoglobulin A (IgA), IgG, IgM or IgE antibodies, proteins, and antigens, for medical purposes used in medical laboratories | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 23, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 9, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 26, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 19, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 19, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 9, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 9, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 2, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 2, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 2, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 15, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 15, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 9, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 12, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 3, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 2, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 2, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 1, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 24, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 24, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 24, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 24, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 11, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 11, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 3, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 2, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 20, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 15, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 15, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 10, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |